Renal microvascular disease predicts renal function in diabetes

Renal Failure

Volumn 34, Issue 1, 2012, Pages 126-129

  Futrakul, Narisa ^a   Futrakul, Prasit ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Royal Institute of Thailand   (Thailand)

Author keywords

Diabetic nephropathy; Hemodynamics; Renal microvascular disease; Vascular homeostasis; Vasodilators

Indexed keywords

CREATININE; NITRIC OXIDE; VASODILATOR AGENT;

ARTICLE; CAPILLARY FLOW; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; FIBROSIS; HOMEOSTASIS; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MICROANGIOPATHY; PRIORITY JOURNAL; PROGRESSIVE TUBULOINTERSTITIAL FIBROSIS; RENAL MICROVASCULAR DISEASE;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; KIDNEY DISEASES; MICROVESSELS;

EID: 84055190491     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.623490     Document Type: Article

References (46)

1. Bellasi A, Furamosca E, Ratti C. Arterial stiffness in chronic kidney disease: The usefulness of a marker of vascular damage. Int J Nephrol. 2011;2011:754832.
2. Takenaka T, Hoshi H, Kato N, et al. Cardio-ankle vascular index to screen cardiovascular disease in patients with end-stage renal disease. J Atheroscler Thromb. 2008;15(6):339-344.
3. Paraskevas KI, Kotsikoris I, Koupidis SA, et al. Ankle-brachial index: A marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010;61:521-523.
4. Hefferuan KS, Kuvir JT, Sarnak MK, et al. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2011;26(8):2515-2521.
5. Bellasi A, Raggi P. Vascular calcification in chronic kidney disease: Usefulness of vascular damage. J Nephrol. 2011;24(Suppl. 18):S11-S15.
6. Marin M, Manez S. Pharmacological interventions on asymmetric dimethylarginine, a clinical marker of vascular disease. Curr Med Chem. 2011;18:714-724.
7. Anderssohn M, Schwedhelm E, Luneburg N, et al. Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus. Diab Vasc Dis Res. 2010;7:105-118.
8. Sniderman A, MoQueen M, Contois J, et al. Why is non-highdensity lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol. 2010;4(1):152-155.
9. Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine- A marker of vascular disease in elderly patients with mental illness. Clin Biochem. 2010;43(13-14):1056-1059.
10. Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34:18-22. (Pubitemid 46860185)
11. Kalea AZ, Schmidt AM, Hudson BI. RAGE: A novel biological and genetic marker of vascular disease. Clin Sci. 2009;116: 621-637.
12. Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Int J Vasc Med. 2011;2011:971524, doi:10.1155/2011/971524.
13. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in chronic kidney disease. Clin Hemorheol Microcirc. 2008;38:201-207. (Pubitemid 351185407)
14. Horvath B, Hegedus D, Szapary L, et al. Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Exp Clin Cardiol. 2004;9:31-34. (Pubitemid 38765356)
15. Del Papa N, Colombo G, Iracchiolla N, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum. 2004;50:1296-1304. (Pubitemid 38480841)
16. Futrakul N, Butthep P, Futrakul P, et al. Glomerular endothelial dysfunction in type 2 diabetes mellitus. Ren Fail. 2006;28:523-524. (Pubitemid 44277680)
17. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006;48:180-186. (Pubitemid 44309805)
18. Garg JP, Bahris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7:35-43. (Pubitemid 34654072)
19. Futrakul N, Sridama V, Futrakul P. Microalbuminuria-A biomarker for renal microvascular disease. Ren Fail. 2009;31:140-143.
20. Lindenmeyer MT, Kaetzler M, Boucherot A, et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol. 2007;18:1765-1776. (Pubitemid 46870313)
21. Futrakul N, Kittikowit W, Yenrudi S. Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis. Ren Fail. 2003;25: 757-746.
22. Bortoloso E, Dol Prete P, Veotra MB, et al. Quantitative and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol. 2004;150:799-807. (Pubitemid 38961653)
23. Yenrudi S, Laohapaibul A, Kittikowit W, et al. A correlation between renal morphology and renal circulation in pediatric nephrotic syndrome. Ren Fail. 2001;23:85-90. (Pubitemid 32207297)
24. Futrakul N, Yenrudi S, Sensirivatana R, et al. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren Fail. 2000;22:329-335. (Pubitemid 30347065)
25. Bohle AC, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res. 1996;192:191-195. (Pubitemid 26379989)
26. Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13:806-816. (Pubitemid 34183950)
27. Nakagawa T, Kang DH, Ohashi R, et al. Tubulointerstitial disease: Role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens. 2003;12:233-241. (Pubitemid 36578057)
28. Futrakul P, Sitprija V, Yenrudi S, et al. Glomerular endothelial dysfunction determines disease progression: A hypothesis. Am J Nephrol. 1997;17:133-140.
29. Futrakul P, Poshyachinda M, Yenrudi S, et al. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: Therapeutic benefit with vasodilator. J Med Assoc Thai. 1992;75:375-385. (Pubitemid 23125776)
30. Futrakul P, Yenrudi S, Futrakul N, et al. Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999;33:886-891 (Pubitemid 29214685)
31. Galesic K, Sabljar-Matovinovic M, Tomic M, et al. Renal vascular resistance in glomerular diseases-Correlation of resistance index with biopsy findings. Coll Antropol. 2004;28: 667-674. (Pubitemid 40115793)
32. Futrakul N, Futrakul P. A mildly altered vascular homeostasis in early stage of CKD. Ren Fail. 2009;31:538-543.
33. Futrakul N, Butthep P, Chunhakan S, et al. Vascular homeostasis in early (normoalbuminuric) type 2 diabetic nephropathy. Asian Biomed. 2010;4:987-990.
34. Natarajan R, Bai W, Lanting L, et al. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cell. Am J Physiol. 1997;273:H2224-H2231.
35. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung CellMol Physiol. 2000;279:L1005-L1028. (Pubitemid 32009487)
36. Vesquez-Viver J, Kalyanaraman S, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 1998;95: 9220-9225. (Pubitemid 28506212)
37. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 1989;35:1093-1106 (Pubitemid 19167894)
38. Zinman B, Hanley AJ, Harris SB, et al. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84:272-278. (Pubitemid 29036713)
39. Thomas MC, Tikellis C, Burno WM, et al. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol. 2005;16:2976-2984. (Pubitemid 44743495)
40. Berg AH, Scherer PE. Odipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-949. (Pubitemid 40712793)
41. Malek AM, Izumo I. Molecular aspects of signal transduction of shear stress in the endothelial cell. J Hypertens. 1994;12: 989-1000.
42. Sachse A, Wolf G. Angiotensin II induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18: 2439-2446. (Pubitemid 47378859)
43. Futrakul N, Butthep P. Early detection of endothelial injury and dysfunction in conjunction with the correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc. 2006;34:373-381.
44. Futrakul N, Kulaputana O, Futrakul P, et al. Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Ren Fail. 2011;33(3):312-315.
45. Ritt M, Ott C, Raff U, et al. Renal vascular endothelial function in hypertensive patients with type 2 diabetes. Am J Kidney Dis. 2009;53:281-289.
46. Karalliedde J, Gnudi L. Future strategies to prevent renal microvascular disease complications in diabetes. Future Cardiol. 2008;4:77-83.